China Galaxy released a research report on April 21 stating that Huadong Pharmaceutical (000963.SZ) was given a recommended rating. The main reasons for the rating include: 1) the pharmaceutical industry is growing steadily, and innovative drug types are progressing steadily; 2) domestic medicine and aesthetics are growing rapidly, and overseas medicine and aesthetics are turning losses into profits. (Mainichi Keizai Shimbun)
中国银河4月21日发布研报称，给予华东医药（000963.SZ）推荐评级。评级理由主要包括：1）医药工业稳定增长，创新药品种稳步推进；2）国内医美快速增长，海外医美扭亏为盈。（每日经济新闻）
China Galaxy released a research report on April 21 stating that Huadong Pharmaceutical (000963.SZ) was given a recommended rating. The main reasons for the rating include: 1) the pharmaceutical industry is growing steadily, and innovative drug types are
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.